We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$558M
AUM Growth
+$80.9M
(+17%)
Cap. Flow
+$74.9M
Cap. Flow
% of AUM
13.41%
Top 10 Holdings %
Top 10 Hldgs %
4.09%
Holding
1,998
New
778
Increased
301
Reduced
272
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$3.2M |
| 2 |
Boeing
BA
|
+$2.64M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.42M |
| 4 |
Amgen
AMGN
|
+$2.03M |
| 5 |
Elevance Health
ELV
|
+$1.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.64M |
| 2 |
Lockheed Martin
LMT
|
+$2.31M |
| 3 |
Cigna
CI
|
+$2.21M |
| 4 |
Wells Fargo
WFC
|
+$2.18M |
| 5 |
Paychex
PAYX
|
+$1.89M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Healthcare | 15.64% |
| 3 | Consumer Discretionary | 14.34% |
| 4 | Industrials | 14.21% |
| 5 | Financials | 12.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FYBR
926
DELISTED
Frontier Communications
FYBR
| $228K | 0.04% |
+12,213
| New | +$229K |
|
927
Bilibili
BILI
$7.55B
| $228K | 0.04% |
+15,073
| New | +$277K |
|
|
RENE
928
DELISTED
Cartesian Growth Corp II
RENE
| $227K | 0.04% |
+21,291
| New | +$225K |
|
929
California Resources
CRC
$4.4B
| $227K | 0.04% |
5,012
-6,366
| -56% | -$258K |
|
930
Amphenol
APH
$177B
| $227K | 0.04% |
+5,342
| New | +$208K |
|
931
Loews
L
$24.6B
| $227K | 0.04% |
+3,821
| New | +$221K |
|
932
Banco Santander Chile
BSAC
$16.2B
| $226K | 0.04% |
+12,015
| New | +$224K |
|
933
Horace Mann Educators
HMN
$2.14B
| $226K | 0.04% |
+7,623
| New | +$242K |
|
934
Cheniere Energy
CQP
$30.5B
| $226K | 0.04% |
+4,894
| New | +$225K |
|
|
MASI
935
DELISTED
Masimo
MASI
| $226K | 0.04% |
+1,372
| New | +$239K |
|
936
Lattice Semiconductor
LSCC
$16.5B
| $225K | 0.04% |
+2,347
| New | +$202K |
|
937
Paycom
PAYC
$7.55B
| $224K | 0.04% |
697
-361
| -34% | -$106K |
|
938
Wave Life Sciences
WVE
$1.12B
| $224K | 0.04% |
+61,461
| New | +$248K |
|
939
Silicon Motion
SIMO
$7.74B
| $223K | 0.04% |
+3,105
| New | +$199K |
|
940
Relay Therapeutics
RLAY
$3.88B
| $223K | 0.04% |
+17,715
| New | +$220K |
|
941
CorVel
CRVL
$3.15B
| $222K | 0.04% |
3,438
-2,292
| -40% | -$153K |
|
|
PRO
942
DELISTED
PROS Holdings
PRO
| $221K | 0.04% |
7,172
-6,998
| -49% | -$197K |
|
943
Atara Biotherapeutics
ATRA
$67.8M
| $220K | 0.04% |
+5,474
| New | +$310K |
|
944
American International
AIG
$42.6B
| $220K | 0.04% |
+3,825
| New | +$205K |
|
945
nLIGHT
LASR
$3.59B
| $219K | 0.04% |
14,231
-25,946
| -65% | -$317K |
|
|
KNTE
946
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $219K | 0.04% |
+72,300
| New | +$279K |
|
947
FTC Solar
FTCI
$46.6M
| $219K | 0.04% |
6,802
-3,423
| -33% | -$94.1K |
|
948
Pliant Therapeutics
PLRX
$67.5M
| $219K | 0.04% |
+12,061
| New | +$286K |
|
|
EBIX
949
DELISTED
Ebix Inc
EBIX
| $217K | 0.04% |
8,630
-16,559
| -66% | -$311K |
|
|
GLDD
950
DELISTED
Great Lakes Dredge & Dock
GLDD
| $217K | 0.04% |
+26,638
| New | +$173K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q2 2023 Portfolio in Review
As of Q2 2023, XTX Topco held 1,998 positions worth $558M, up 17% from $477M the previous quarter. Its ten largest holdings account for 4.1% of the portfolio.
XTX Topco deployed $74.9M of net new capital in Q2 2023, opening 778 new positions and adding to 301 existing holdings. Its largest new stake was Target: 21,561 shares worth $2.84M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lockheed Martin, an estimated $2.31M trimmed.
- XTX Topco's largest Q2 2023 buy was Target: 21,561 shares worth $2.84M.
- XTX Topco added most to Alphabet (Google) Class A in Q2 2023, an estimated $2.42M increase.
- XTX Topco's biggest Q2 2023 reduction was Lockheed Martin, cutting an estimated $2.31M.
- XTX Topco fully exited Regeneron Pharmaceuticals in Q2 2023, selling an estimated $2.64M.
- XTX Topco's ten largest holdings make up 4.1% of its $558M portfolio in Q2 2023.
- XTX Topco opened 778 new positions and closed 643 in Q2 2023.
- XTX Topco's portfolio value rose 17% quarter-over-quarter to $558M.
Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.